Wall Street Lunch: AI-Designed Drugs Expected To See Trials This Year
Google's DeepMind spinoff Isomorphic Labs expects clinical trials of drugs designed using AI to start late this year.
朝日新聞社7d
Nobel-winning AI developer says risks must also be assessed
Hassabis, 48, CEO and co-founder of Google DeepMind, developed the AI model AlphaFold to predict protein structure with company co-founder John Jumper. Proteins are made up of amino acids linked ...
AI-developed drug will be in trials by year-end, says Google’s Hassabis
Isomorphic was spun out of Google’s AI research arm Google DeepMind in 2021, but remains a wholly owned subsidiary of its parent company, Alphabet. The start-up’s potential has attracted big ...
DeepMind’s Hassabis Sees AI-Designed Drug Trials This Year
Google DeepMind spinoff Isomorphic Labs expects research of drugs it designed using artificial intelligence will begin this year, according to its Nobel Prize-winning chief executive officer.Most Read ...
中国日报网29d
AI reshaping global future in a new year
With the unprecedented advancement of technology, artificial intelligence is rapidly transforming societies and elevating global collaboration to new heights. AI has already made groundbreaking ...